| Symbol | ENTBF |
|---|---|
| Name | ENTHEON BIOMEDICAL CORP. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | V5Z 1K5 Canada BC Suite 720-999 W Broadway Street |
| Telephone | +1 604-562-3932 |
| Fax | — |
| — | |
| Website | http://entheonbiomedical.com |
| Incorporation | CA |
| Incorporated On | 2010 |
| Employees | — |
| Fiscal Year | 11/30 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Manning Elliott LLP; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Canadian Securities Exchange |
| CIK | 0001814903 |
| Description | Entheon is a biotechnology research and development company interested in treating addiction and substance use disorders. Additional info from OTC: |
No news found.